HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Pallab Bhattacharya Selected Research

Piroxicam (Feldene)

9/2015Piroxicam-mediated modulatory action of 5-hydroxytryptamine serves as a "brake" on neuronal excitability in ischemic stroke.
12/2014Alleviation of glutamate mediated neuronal insult by piroxicam in rodent model of focal cerebral ischemia: a possible mechanism of GABA agonism.
12/2014Inhibition of matrix metalloproteinase-2 and 9 by Piroxicam confer neuroprotection in cerebral ischemia: an in silico evaluation of the hypothesis.
9/2013Does Piroxicam really protect ischemic neurons and influence neuronal firing in cerebral ischemia? An exploration towards therapeutics.
1/2013Aquaporin-4 inhibition mediates piroxicam-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rodents.
10/2012Combination therapy of ifenprodil with piroxicam may be an effective therapeutic intervention in cerebral stroke: a hypothesis.
9/2012Neuroprotective potential of Piroxicam in cerebral ischemia: an in silico evaluation of the hypothesis to explore its therapeutic efficacy by inhibition of aquaporin-4 and acid sensing ion channel1a.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Pallab Bhattacharya Research Topics

Disease

11Brain Ischemia (Cerebral Ischemia)
04/2015 - 12/2011
8Stroke (Strokes)
09/2015 - 07/2012
3Brain Edema (Cerebral Edema)
04/2015 - 01/2013
2Ischemia
04/2014 - 01/2013
2Reperfusion Injury
09/2013 - 01/2013
1Nervous System Diseases (Neurological Disorders)
12/2014
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
04/2014
1Substance-Related Disorders (Drug Abuse)
10/2012
1Parkinson Disease (Parkinson's Disease)
10/2012
1Alcoholism (Alcohol Abuse)
10/2012

Drug/Important Bio-Agent (IBA)

7Piroxicam (Feldene)FDA LinkGeneric
09/2015 - 09/2012
3Malondialdehyde (Propanedial)IBA
04/2015 - 01/2013
3Matrix MetalloproteinasesIBA
04/2015 - 07/2012
2Neurotransmitter Agents (Neurotransmitter)IBA
12/2014 - 09/2012
1Serotonin (5 Hydroxytryptamine)IBA
09/2015
1resveratrolIBA
04/2015
1Glutamic Acid (Glutamate)FDA Link
12/2014
1ZincIBA
12/2014
1gamma-Aminobutyric Acid (GABA)IBA
12/2014
1EndopeptidasesIBA
12/2014
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
12/2014
1Protein Kinase CIBA
04/2014
1MelatoninIBA
04/2014
1ifenprodilIBA
10/2012
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2012
1Tissue Plasminogen Activator (Alteplase)FDA Link
09/2012
1Ion Channels (Ion Channel)IBA
07/2012
1FlavonoidsIBA
07/2012
1QuercetinIBA
07/2012
1CalciumIBA
12/2011
1Minocycline (Cyclops)FDA LinkGeneric
12/2011
1MagnesiumIBA
12/2011

Therapy/Procedure

2Therapeutics
01/2013 - 09/2012
2Drug Therapy (Chemotherapy)
10/2012 - 09/2012